View ValuationTapex 将来の成長Future 基準チェック /06現在、 Tapexの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長63.8%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報Major Estimate Revision • Apr 29Consensus revenue estimates decrease by 16%The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from ₩229.9m to ₩192.2m. EPS estimate unchanged from ₩4,582 per share at last update. Chemicals industry in South Korea expected to see average net income growth of 31% next year. Consensus price target of ₩100,000 unchanged from last update. Share price fell 3.5% to ₩55,000 over the past week.Price Target Changed • Nov 16Price target decreased to ₩100,000Down from ₩110,000, the current price target is provided by 1 analyst. New target price is 55% above last closing price of ₩64,600. Stock is down 20% over the past year. The company is forecast to post earnings per share of ₩4,945 for next year compared to ₩4,009 last year.すべての更新を表示Recent updatesValuation Update With 7 Day Price Move • May 12Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩17,420, the stock trades at a trailing P/E ratio of 41.2x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total loss to shareholders of 63% over the past three years.Valuation Update With 7 Day Price Move • Mar 30Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩16,490, the stock trades at a trailing P/E ratio of 39x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total loss to shareholders of 72% over the past three years.Reported Earnings • Mar 20Full year 2025 earnings released: EPS: ₩423 (vs ₩751 in FY 2024)Full year 2025 results: EPS: ₩423 (down from ₩751 in FY 2024). Revenue: ₩141.1b (up 3.8% from FY 2024). Net income: ₩2.02b (down 44% from FY 2024). Profit margin: 1.4% (down from 2.6% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 44 percentage points per year, which is a significant difference in performance.Valuation Update With 7 Day Price Move • Mar 04Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩13,520, the stock trades at a trailing P/E ratio of 34.8x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 77% over the past three years.分析記事 • Feb 08Tapex (KRX:055490) Is Paying Out A Dividend Of ₩200.00Tapex Co., Ltd. ( KRX:055490 ) will pay a dividend of ₩200.00 on the 1st of January. Including this payment, the...Declared Dividend • Feb 07Dividend of ₩200 announcedDividend of ₩200 is the same as last year. Ex-date: 26th March 2026 Payment date: 1st January 1970 Dividend yield will be 1.4%, which is lower than the industry average of 1.7%. Sustainability & Growth Dividend is covered by earnings (52% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 56 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to decline by 43% to shift the payout ratio to a potentially unsustainable range, which is more than the 34% EPS decline seen over the last 5 years.お知らせ • Feb 06+ 1 more updateTapex Co., Ltd. announces Annual dividendTapex Co., Ltd. announced Annual dividend of KRW 200.0000 per share, ex-date on March 26, 2026 and record date on March 27, 2026.分析記事 • Nov 19Why Tapex's (KRX:055490) Shaky Earnings Are Just The Beginning Of Its ProblemsA lackluster earnings announcement from Tapex Co., Ltd. ( KRX:055490 ) last week didn't sink the stock price. Our...Reported Earnings • Nov 14Third quarter 2025 earnings released: EPS: ₩422 (vs ₩303 in 3Q 2024)Third quarter 2025 results: EPS: ₩422 (up from ₩303 in 3Q 2024). Revenue: ₩37.4b (up 14% from 3Q 2024). Net income: ₩2.02b (up 39% from 3Q 2024). Profit margin: 5.4% (up from 4.4% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 46 percentage points per year, which is a significant difference in performance.分析記事 • Nov 06Optimistic Investors Push Tapex Co., Ltd. (KRX:055490) Shares Up 31% But Growth Is LackingTapex Co., Ltd. ( KRX:055490 ) shares have had a really impressive month, gaining 31% after a shaky period beforehand...Valuation Update With 7 Day Price Move • Nov 06Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₩17,940, the stock trades at a trailing P/E ratio of 66.6x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 69% over the past three years.Reported Earnings • Aug 19Second quarter 2025 earnings released: ₩154 loss per share (vs ₩83.00 profit in 2Q 2024)Second quarter 2025 results: ₩154 loss per share (down from ₩83.00 profit in 2Q 2024). Revenue: ₩35.8b (down 4.7% from 2Q 2024). Net loss: ₩733.9m (down ₩861.8m from profit in 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 39 percentage points per year, which is a significant difference in performance.分析記事 • Aug 13Tapex Co., Ltd.'s (KRX:055490) 28% Share Price Surge Not Quite Adding UpKOSE:A055490 1 Year Share Price vs Fair Value Explore Tapex's Fair Values from the Community and select yours Tapex...分析記事 • Jul 21Tapex (KRX:055490) Takes On Some Risk With Its Use Of DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...分析記事 • May 20Weak Statutory Earnings May Not Tell The Whole Story For Tapex (KRX:055490)The subdued market reaction suggests that Tapex Co., Ltd.'s ( KRX:055490 ) recent earnings didn't contain any...Reported Earnings • May 19First quarter 2025 earnings released: ₩240 loss per share (vs ₩61.00 profit in 1Q 2024)First quarter 2025 results: ₩240 loss per share (down from ₩61.00 profit in 1Q 2024). Revenue: ₩31.1b (down 11% from 1Q 2024). Net loss: ₩1.15b (down 495% from profit in 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 25 percentage points per year, which is a significant difference in performance.Board Change • Apr 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. CEO & Director Kim Sang-Goo was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Reported Earnings • Mar 13Full year 2024 earnings released: EPS: ₩751 (vs ₩1,708 in FY 2023)Full year 2024 results: EPS: ₩751 (down from ₩1,708 in FY 2023). Revenue: ₩136.0b (down 6.8% from FY 2023). Net income: ₩3.58b (down 56% from FY 2023). Profit margin: 2.6% (down from 5.6% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has only fallen by 43% per year, which means it has not declined as severely as earnings.分析記事 • Feb 19These 4 Measures Indicate That Tapex (KRX:055490) Is Using Debt ExtensivelyWarren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...お知らせ • Feb 19Tapex Co., Ltd. announces Annual dividendTapex Co., Ltd. announced Annual dividend of KRW 200.0000 per share, ex-date on March 20, 2025 and record date on March 21, 2025.Buy Or Sell Opportunity • Feb 05Now 22% overvaluedOver the last 90 days, the stock has fallen 20% to ₩12,650. The fair value is estimated to be ₩10,368, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 5.0% over the last 3 years. Earnings per share has declined by 50%.お知らせ • Feb 04Tapex Co., Ltd., Annual General Meeting, Mar 18, 2025Tapex Co., Ltd., Annual General Meeting, Mar 18, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 62-16, chorok-ro 532beon-gil, yanggam-myeon, gyeonggi-do, hwaseong South KoreaBuy Or Sell Opportunity • Jan 03Now 26% overvaluedOver the last 90 days, the stock has fallen 26% to ₩13,260. The fair value is estimated to be ₩10,500, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 5.0% over the last 3 years. Earnings per share has declined by 50%.Buy Or Sell Opportunity • Dec 10Now 23% overvaluedOver the last 90 days, the stock has fallen 29% to ₩12,720. The fair value is estimated to be ₩10,353, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 5.0% over the last 3 years. Earnings per share has declined by 50%.分析記事 • Nov 15Weak Statutory Earnings May Not Tell The Whole Story For Tapex (KRX:055490)The market wasn't impressed with the soft earnings from Tapex Co., Ltd. ( KRX:055490 ) recently. We did some analysis...Reported Earnings • Nov 12Third quarter 2024 earnings released: EPS: ₩303 (vs ₩318 in 3Q 2023)Third quarter 2024 results: EPS: ₩303 (down from ₩318 in 3Q 2023). Revenue: ₩32.7b (down 8.5% from 3Q 2023). Net income: ₩1.45b (down 3.9% from 3Q 2023). Profit margin: 4.4% (up from 4.2% in 3Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 43% per year, which means it has not declined as severely as earnings.分析記事 • Nov 11These 4 Measures Indicate That Tapex (KRX:055490) Is Using Debt ExtensivelyWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Reported Earnings • Aug 16Second quarter 2024 earnings released: EPS: ₩83.00 (vs ₩669 in 2Q 2023)Second quarter 2024 results: EPS: ₩83.00 (down from ₩669 in 2Q 2023). Revenue: ₩37.6b (down 2.9% from 2Q 2023). Net income: ₩397.5m (down 87% from 2Q 2023). Profit margin: 1.1% (down from 8.2% in 2Q 2023). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 38% per year whereas the company’s share price has fallen by 35% per year.Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₩16,880, the stock trades at a trailing P/E ratio of 13.1x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 72% over the past three years.分析記事 • Jul 14More Unpleasant Surprises Could Be In Store For Tapex Co., Ltd.'s (KRX:055490) Shares After Tumbling 25%Tapex Co., Ltd. ( KRX:055490 ) shares have retraced a considerable 25% in the last month, reversing a fair amount of...New Risk • Jun 05New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risk Profit margins are more than 30% lower than last year (4.2% net profit margin).Valuation Update With 7 Day Price Move • Jun 05Investor sentiment improves as stock rises 27%After last week's 27% share price gain to ₩31,550, the stock trades at a trailing P/E ratio of 24.5x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total loss to shareholders of 37% over the past three years.分析記事 • May 27What Tapex Co., Ltd.'s (KRX:055490) 25% Share Price Gain Is Not Telling YouTapex Co., Ltd. ( KRX:055490 ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...New Risk • May 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (20% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (9.1% average weekly change). Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (₩126.3b market cap, or US$92.4m).分析記事 • May 02Tapex (KRX:055490) Takes On Some Risk With Its Use Of DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Valuation Update With 7 Day Price Move • May 02Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₩25,800, the stock trades at a trailing P/E ratio of 15.2x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total loss to shareholders of 54% over the past three years.分析記事 • Mar 13Tapex's (KRX:055490) Weak Earnings May Only Reveal A Part Of The Whole PictureDespite Tapex Co., Ltd.'s ( KRX:055490 ) recent earnings report having lackluster headline numbers, the market...Valuation Update With 7 Day Price Move • Mar 13Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₩26,800, the stock trades at a trailing P/E ratio of 15.8x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total loss to shareholders of 35% over the past three years.Reported Earnings • Mar 12Full year 2023 earnings released: EPS: ₩1,708 (vs ₩4,013 in FY 2022)Full year 2023 results: EPS: ₩1,708 (down from ₩4,013 in FY 2022). Revenue: ₩145.8b (down 20% from FY 2022). Net income: ₩8.10b (down 57% from FY 2022). Profit margin: 5.6% (down from 10% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 14% per year and the company’s share price has also fallen by 14% per year.分析記事 • Mar 08Tapex Co., Ltd.'s (KRX:055490) Business Is Trailing The Market But Its Shares Aren'tWith a price-to-earnings (or "P/E") ratio of 16.5x Tapex Co., Ltd. ( KRX:055490 ) may be sending bearish signals at the...Upcoming Dividend • Dec 20Upcoming dividend of ₩900 per share at 3.1% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 11 April 2024. Payout ratio is a comfortable 58% and this is well supported by cash flows. Trailing yield: 3.1%. Lower than top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.8%).Reported Earnings • Nov 15Third quarter 2023 earnings released: EPS: ₩318 (vs ₩1,185 in 3Q 2022)Third quarter 2023 results: EPS: ₩318 (down from ₩1,185 in 3Q 2022). Revenue: ₩35.7b (down 21% from 3Q 2022). Net income: ₩1.51b (down 73% from 3Q 2022). Profit margin: 4.2% (down from 12% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 3% per year.Valuation Update With 7 Day Price Move • Nov 03Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₩33,700, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 11% over the past three years.New Risk • Oct 26New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩131.5b (US$96.8m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (7.1% net profit margin). Market cap is less than US$100m (₩131.5b market cap, or US$96.8m).Valuation Update With 7 Day Price Move • Aug 09Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩40,500, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 65% over the past three years.Major Estimate Revision • Apr 29Consensus revenue estimates decrease by 16%The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from ₩229.9m to ₩192.2m. EPS estimate unchanged from ₩4,582 per share at last update. Chemicals industry in South Korea expected to see average net income growth of 31% next year. Consensus price target of ₩100,000 unchanged from last update. Share price fell 3.5% to ₩55,000 over the past week.Buying Opportunity • Apr 04Now 21% undervaluedOver the last 90 days, the stock is up 16%. The fair value is estimated to be ₩75,380, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 20% over the last 3 years. Earnings per share has grown by 29%. Revenue is forecast to grow by 61% in 2 years. Earnings is forecast to grow by 102% in the next 2 years.Buying Opportunity • Mar 10Now 23% undervalued after recent price dropOver the last 90 days, the stock is down 1.2%. The fair value is estimated to be ₩75,253, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 20% over the last 3 years. Earnings per share has grown by 29%. Revenue is forecast to grow by 61% in 2 years. Earnings is forecast to grow by 102% in the next 2 years.Reported Earnings • Mar 09Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: ₩4,013 (up from ₩4,009 in FY 2021). Revenue: ₩182.3b (up 18% from FY 2021). Net income: ₩18.9b (flat on FY 2021). Profit margin: 10% (down from 12% in FY 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 6.0%. Earnings per share (EPS) also missed analyst estimates by 19%. Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Mar 06Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩63,200, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 261% over the past three years.Buying Opportunity • Jan 16Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 23%. The fair value is estimated to be ₩66,167, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 37%. Revenue is forecast to grow by 48% in 2 years. Earnings is forecast to grow by 60% in the next 2 years.Upcoming Dividend • Dec 21Upcoming dividend of ₩700 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 12 April 2023. Payout ratio is a comfortable 15% and this is well supported by cash flows. Trailing yield: 1.4%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (2.4%).Buying Opportunity • Dec 12Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 22%. The fair value is estimated to be ₩72,854, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 37%. Revenue is forecast to grow by 48% in 2 years. Earnings is forecast to grow by 60% in the next 2 years.Buying Opportunity • Nov 17Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 23%. The fair value is estimated to be ₩79,792, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 37%. Revenue is forecast to grow by 48% in 2 years. Earnings is forecast to grow by 59% in the next 2 years.Price Target Changed • Nov 16Price target decreased to ₩100,000Down from ₩110,000, the current price target is provided by 1 analyst. New target price is 55% above last closing price of ₩64,600. Stock is down 20% over the past year. The company is forecast to post earnings per share of ₩4,945 for next year compared to ₩4,009 last year.Reported Earnings • Nov 13Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: ₩45.4b (up 11% from 3Q 2021). Net income: ₩5.59b (up 2.0% from 3Q 2021). Profit margin: 12% (down from 13% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in South Korea.Buying Opportunity • Nov 07Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 24%. The fair value is estimated to be ₩75,747, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 41%. Revenue is forecast to grow by 43% in 2 years. Earnings is forecast to grow by 51% in the next 2 years.Reported Earnings • Mar 12Full year 2021 earnings: EPS misses analyst expectationsFull year 2021 results: EPS: ₩4,009 (up from ₩2,931 in FY 2020). Revenue: ₩154.9b (up 30% from FY 2020). Net income: ₩18.9b (up 37% from FY 2020). Profit margin: 12% (in line with FY 2020). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 37%, compared to a 22% growth forecast for the industry in South Korea. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has increased by 57% per year, which means it is tracking significantly ahead of earnings growth.Upcoming Dividend • Dec 22Upcoming dividend of ₩500 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 15 April 2022. Payout ratio is a comfortable 14% but the company is not cash flow positive. Trailing yield: 0.7%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (1.4%).Reported Earnings • Nov 13Third quarter 2021 earnings released: EPS ₩1,162 (vs ₩938 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: ₩40.9b (up 28% from 3Q 2020). Net income: ₩5.48b (up 24% from 3Q 2020). Profit margin: 13% (in line with 3Q 2020). Over the last 3 years on average, earnings per share has increased by 48% per year whereas the company’s share price has increased by 49% per year.Reported Earnings • Aug 12Second quarter 2021 earnings released: EPS ₩1,041 (vs ₩1,038 in 2Q 2020)The company reported a mediocre second quarter result with weaker profit margins, although earnings were flat and revenues improved. Second quarter 2021 results: Revenue: ₩36.3b (up 30% from 2Q 2020). Net income: ₩4.91b (flat on 2Q 2020). Profit margin: 14% (down from 18% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has only increased by 38% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Aug 11Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₩69,400, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 155% over the past three years.Reported Earnings • May 12First quarter 2021 earnings released: EPS ₩945 (vs ₩437 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ₩33.3b (up 23% from 1Q 2020). Net income: ₩4.46b (up 116% from 1Q 2020). Profit margin: 13% (up from 7.6% in 1Q 2020). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.分析記事 • May 04Is Tapex Co., Ltd. (KRX:055490) Potentially Undervalued?Tapex Co., Ltd. ( KRX:055490 ), is not the largest company out there, but it led the KOSE gainers with a relatively...Valuation Update With 7 Day Price Move • Mar 26Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₩51,800, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 91% over the past three years.分析記事 • Mar 23We Think Tapex (KRX:055490) Can Manage Its Debt With EaseHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Reported Earnings • Mar 10Full year 2020 earnings released: EPS ₩2,931 (vs ₩1,617 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₩118.8b (up 5.5% from FY 2019). Net income: ₩13.8b (up 81% from FY 2019). Profit margin: 12% (up from 6.8% in FY 2019). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.分析記事 • Mar 08What You Need To Know About Tapex Co., Ltd.'s (KRX:055490) Investor CompositionEvery investor in Tapex Co., Ltd. ( KRX:055490 ) should be aware of the most powerful shareholder groups. Large...分析記事 • Feb 18Is Tapex (KRX:055490) Likely To Turn Things Around?If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...お知らせ • Feb 04Tapex Co., Ltd., Annual General Meeting, Mar 22, 2021Tapex Co., Ltd., Annual General Meeting, Mar 22, 2021, at 09:00 Korea Standard Time.分析記事 • Jan 31Is Tapex Co., Ltd.'s (KRX:055490) Latest Stock Performance A Reflection Of Its Financial Health?Most readers would already be aware that Tapex's (KRX:055490) stock increased significantly by 29% over the past three...Valuation Update With 7 Day Price Move • Jan 20Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₩42,650, the stock is trading at a trailing P/E ratio of 13.9x, up from the previous P/E ratio of 12x. This compares to an average P/E of 18x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 51%.分析記事 • Jan 12Should You Rely On Tapex's (KRX:055490) Earnings Growth?Many investors consider it preferable to invest in profitable companies over unprofitable ones, because profitability...Is New 90 Day High Low • Jan 04New 90-day high: ₩38,550The company is up 25% from its price of ₩30,950 on 06 October 2020. The South Korean market is up 21% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 22% over the same period.分析記事 • Dec 25Investors Who Bought Tapex (KRX:055490) Shares A Year Ago Are Now Up 65%Passive investing in index funds can generate returns that roughly match the overall market. But investors can boost...Is New 90 Day High Low • Dec 16New 90-day high: ₩37,700The company is up 8.0% from its price of ₩34,800 on 17 September 2020. The South Korean market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period.分析記事 • Dec 07Tapex (KRX:055490) Has A Rock Solid Balance SheetSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Is New 90 Day High Low • Nov 30New 90-day high: ₩36,900The company is up 48% from its price of ₩25,000 on 01 September 2020. The South Korean market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period.Reported Earnings • Nov 14Third quarter 2020 earnings released: EPS ₩938The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: ₩31.8b (up 5.3% from 3Q 2019). Net income: ₩4.43b (up 159% from 3Q 2019). Profit margin: 14% (up from 5.6% in 3Q 2019). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Tapex は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測KOSE:A055490 - アナリストの将来予測と過去の財務データ ( )KRW Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/2026148,6895,1444,36010,773N/A12/31/2025141,1392,0175,89314,112N/A9/30/2025134,9151,852-5,993954N/A6/30/2025130,2261,284-27210,666N/A3/31/2025131,9922,415-3,48510,960N/A12/31/2024135,9553,581-7,64811,469N/A9/30/2024140,3913,032-7,75419,398N/A6/30/2024143,4453,091-11,03514,094N/A3/31/2024144,5495,861-10,80716,400N/A12/31/2023145,8408,104-19,5329,350N/A9/30/2023150,9137,298-7,11815,889N/A6/30/2023160,57811,384-5,46215,283N/A3/31/2023172,15215,4895,45521,167N/A12/31/2022182,26118,93318,22225,589N/A9/30/2022186,59722,63621,53525,568N/A6/30/2022182,04122,52420,13925,323N/A3/31/2022168,03220,1612,65311,976N/A12/31/2021154,92318,91145912,066N/A9/30/2021142,46817,292-5,5736,923N/A6/30/2021133,43416,237-3,3497,238N/A3/31/2021125,07616,2256,24911,166N/A12/31/2020118,77313,82812,31415,192N/A9/30/2020115,18014,52615,20616,552N/A6/30/2020113,57911,80715,56816,720N/A3/31/2020112,6058,55015,51916,559N/A12/31/2019112,6057,630N/A13,122N/A9/30/2019112,1315,773N/A9,806N/A6/30/2019110,1705,188N/A6,690N/A3/31/2019109,1464,782N/A4,384N/A12/31/2018108,4995,101N/A4,485N/A9/30/2018105,2625,347N/A6,973N/A6/30/2018104,1816,321N/A8,767N/A3/31/2018105,4547,929N/A11,873N/A12/31/2017105,8527,650N/A12,207N/A9/30/2017107,9756,710N/A10,650N/A6/30/2017107,6405,206N/A9,908N/A3/31/201785,4152,019N/A6,212N/A12/31/201663,584491N/A5,355N/A12/31/2015113,2929,531N/A13,519N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: A055490の予測収益成長が 貯蓄率 ( 3.1% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: A055490の収益がKR市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: A055490の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: A055490の収益がKR市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: A055490の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: A055490の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 12:43終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Tapex Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関Kyung-rae HanDaishin Securities Co. Ltd.Sang-Hun LeeiM SecuritiesNeul HaNH Investment & Securities Co., Ltd.1 その他のアナリストを表示
Major Estimate Revision • Apr 29Consensus revenue estimates decrease by 16%The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from ₩229.9m to ₩192.2m. EPS estimate unchanged from ₩4,582 per share at last update. Chemicals industry in South Korea expected to see average net income growth of 31% next year. Consensus price target of ₩100,000 unchanged from last update. Share price fell 3.5% to ₩55,000 over the past week.
Price Target Changed • Nov 16Price target decreased to ₩100,000Down from ₩110,000, the current price target is provided by 1 analyst. New target price is 55% above last closing price of ₩64,600. Stock is down 20% over the past year. The company is forecast to post earnings per share of ₩4,945 for next year compared to ₩4,009 last year.
Valuation Update With 7 Day Price Move • May 12Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩17,420, the stock trades at a trailing P/E ratio of 41.2x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total loss to shareholders of 63% over the past three years.
Valuation Update With 7 Day Price Move • Mar 30Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩16,490, the stock trades at a trailing P/E ratio of 39x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total loss to shareholders of 72% over the past three years.
Reported Earnings • Mar 20Full year 2025 earnings released: EPS: ₩423 (vs ₩751 in FY 2024)Full year 2025 results: EPS: ₩423 (down from ₩751 in FY 2024). Revenue: ₩141.1b (up 3.8% from FY 2024). Net income: ₩2.02b (down 44% from FY 2024). Profit margin: 1.4% (down from 2.6% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 44 percentage points per year, which is a significant difference in performance.
Valuation Update With 7 Day Price Move • Mar 04Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩13,520, the stock trades at a trailing P/E ratio of 34.8x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 77% over the past three years.
分析記事 • Feb 08Tapex (KRX:055490) Is Paying Out A Dividend Of ₩200.00Tapex Co., Ltd. ( KRX:055490 ) will pay a dividend of ₩200.00 on the 1st of January. Including this payment, the...
Declared Dividend • Feb 07Dividend of ₩200 announcedDividend of ₩200 is the same as last year. Ex-date: 26th March 2026 Payment date: 1st January 1970 Dividend yield will be 1.4%, which is lower than the industry average of 1.7%. Sustainability & Growth Dividend is covered by earnings (52% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 56 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to decline by 43% to shift the payout ratio to a potentially unsustainable range, which is more than the 34% EPS decline seen over the last 5 years.
お知らせ • Feb 06+ 1 more updateTapex Co., Ltd. announces Annual dividendTapex Co., Ltd. announced Annual dividend of KRW 200.0000 per share, ex-date on March 26, 2026 and record date on March 27, 2026.
分析記事 • Nov 19Why Tapex's (KRX:055490) Shaky Earnings Are Just The Beginning Of Its ProblemsA lackluster earnings announcement from Tapex Co., Ltd. ( KRX:055490 ) last week didn't sink the stock price. Our...
Reported Earnings • Nov 14Third quarter 2025 earnings released: EPS: ₩422 (vs ₩303 in 3Q 2024)Third quarter 2025 results: EPS: ₩422 (up from ₩303 in 3Q 2024). Revenue: ₩37.4b (up 14% from 3Q 2024). Net income: ₩2.02b (up 39% from 3Q 2024). Profit margin: 5.4% (up from 4.4% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 46 percentage points per year, which is a significant difference in performance.
分析記事 • Nov 06Optimistic Investors Push Tapex Co., Ltd. (KRX:055490) Shares Up 31% But Growth Is LackingTapex Co., Ltd. ( KRX:055490 ) shares have had a really impressive month, gaining 31% after a shaky period beforehand...
Valuation Update With 7 Day Price Move • Nov 06Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₩17,940, the stock trades at a trailing P/E ratio of 66.6x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 69% over the past three years.
Reported Earnings • Aug 19Second quarter 2025 earnings released: ₩154 loss per share (vs ₩83.00 profit in 2Q 2024)Second quarter 2025 results: ₩154 loss per share (down from ₩83.00 profit in 2Q 2024). Revenue: ₩35.8b (down 4.7% from 2Q 2024). Net loss: ₩733.9m (down ₩861.8m from profit in 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 39 percentage points per year, which is a significant difference in performance.
分析記事 • Aug 13Tapex Co., Ltd.'s (KRX:055490) 28% Share Price Surge Not Quite Adding UpKOSE:A055490 1 Year Share Price vs Fair Value Explore Tapex's Fair Values from the Community and select yours Tapex...
分析記事 • Jul 21Tapex (KRX:055490) Takes On Some Risk With Its Use Of DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
分析記事 • May 20Weak Statutory Earnings May Not Tell The Whole Story For Tapex (KRX:055490)The subdued market reaction suggests that Tapex Co., Ltd.'s ( KRX:055490 ) recent earnings didn't contain any...
Reported Earnings • May 19First quarter 2025 earnings released: ₩240 loss per share (vs ₩61.00 profit in 1Q 2024)First quarter 2025 results: ₩240 loss per share (down from ₩61.00 profit in 1Q 2024). Revenue: ₩31.1b (down 11% from 1Q 2024). Net loss: ₩1.15b (down 495% from profit in 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 25 percentage points per year, which is a significant difference in performance.
Board Change • Apr 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. CEO & Director Kim Sang-Goo was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Reported Earnings • Mar 13Full year 2024 earnings released: EPS: ₩751 (vs ₩1,708 in FY 2023)Full year 2024 results: EPS: ₩751 (down from ₩1,708 in FY 2023). Revenue: ₩136.0b (down 6.8% from FY 2023). Net income: ₩3.58b (down 56% from FY 2023). Profit margin: 2.6% (down from 5.6% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has only fallen by 43% per year, which means it has not declined as severely as earnings.
分析記事 • Feb 19These 4 Measures Indicate That Tapex (KRX:055490) Is Using Debt ExtensivelyWarren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
お知らせ • Feb 19Tapex Co., Ltd. announces Annual dividendTapex Co., Ltd. announced Annual dividend of KRW 200.0000 per share, ex-date on March 20, 2025 and record date on March 21, 2025.
Buy Or Sell Opportunity • Feb 05Now 22% overvaluedOver the last 90 days, the stock has fallen 20% to ₩12,650. The fair value is estimated to be ₩10,368, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 5.0% over the last 3 years. Earnings per share has declined by 50%.
お知らせ • Feb 04Tapex Co., Ltd., Annual General Meeting, Mar 18, 2025Tapex Co., Ltd., Annual General Meeting, Mar 18, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 62-16, chorok-ro 532beon-gil, yanggam-myeon, gyeonggi-do, hwaseong South Korea
Buy Or Sell Opportunity • Jan 03Now 26% overvaluedOver the last 90 days, the stock has fallen 26% to ₩13,260. The fair value is estimated to be ₩10,500, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 5.0% over the last 3 years. Earnings per share has declined by 50%.
Buy Or Sell Opportunity • Dec 10Now 23% overvaluedOver the last 90 days, the stock has fallen 29% to ₩12,720. The fair value is estimated to be ₩10,353, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 5.0% over the last 3 years. Earnings per share has declined by 50%.
分析記事 • Nov 15Weak Statutory Earnings May Not Tell The Whole Story For Tapex (KRX:055490)The market wasn't impressed with the soft earnings from Tapex Co., Ltd. ( KRX:055490 ) recently. We did some analysis...
Reported Earnings • Nov 12Third quarter 2024 earnings released: EPS: ₩303 (vs ₩318 in 3Q 2023)Third quarter 2024 results: EPS: ₩303 (down from ₩318 in 3Q 2023). Revenue: ₩32.7b (down 8.5% from 3Q 2023). Net income: ₩1.45b (down 3.9% from 3Q 2023). Profit margin: 4.4% (up from 4.2% in 3Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 43% per year, which means it has not declined as severely as earnings.
分析記事 • Nov 11These 4 Measures Indicate That Tapex (KRX:055490) Is Using Debt ExtensivelyWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Reported Earnings • Aug 16Second quarter 2024 earnings released: EPS: ₩83.00 (vs ₩669 in 2Q 2023)Second quarter 2024 results: EPS: ₩83.00 (down from ₩669 in 2Q 2023). Revenue: ₩37.6b (down 2.9% from 2Q 2023). Net income: ₩397.5m (down 87% from 2Q 2023). Profit margin: 1.1% (down from 8.2% in 2Q 2023). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 38% per year whereas the company’s share price has fallen by 35% per year.
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₩16,880, the stock trades at a trailing P/E ratio of 13.1x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 72% over the past three years.
分析記事 • Jul 14More Unpleasant Surprises Could Be In Store For Tapex Co., Ltd.'s (KRX:055490) Shares After Tumbling 25%Tapex Co., Ltd. ( KRX:055490 ) shares have retraced a considerable 25% in the last month, reversing a fair amount of...
New Risk • Jun 05New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risk Profit margins are more than 30% lower than last year (4.2% net profit margin).
Valuation Update With 7 Day Price Move • Jun 05Investor sentiment improves as stock rises 27%After last week's 27% share price gain to ₩31,550, the stock trades at a trailing P/E ratio of 24.5x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total loss to shareholders of 37% over the past three years.
分析記事 • May 27What Tapex Co., Ltd.'s (KRX:055490) 25% Share Price Gain Is Not Telling YouTapex Co., Ltd. ( KRX:055490 ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...
New Risk • May 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (20% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (9.1% average weekly change). Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (₩126.3b market cap, or US$92.4m).
分析記事 • May 02Tapex (KRX:055490) Takes On Some Risk With Its Use Of DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Valuation Update With 7 Day Price Move • May 02Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₩25,800, the stock trades at a trailing P/E ratio of 15.2x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total loss to shareholders of 54% over the past three years.
分析記事 • Mar 13Tapex's (KRX:055490) Weak Earnings May Only Reveal A Part Of The Whole PictureDespite Tapex Co., Ltd.'s ( KRX:055490 ) recent earnings report having lackluster headline numbers, the market...
Valuation Update With 7 Day Price Move • Mar 13Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₩26,800, the stock trades at a trailing P/E ratio of 15.8x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total loss to shareholders of 35% over the past three years.
Reported Earnings • Mar 12Full year 2023 earnings released: EPS: ₩1,708 (vs ₩4,013 in FY 2022)Full year 2023 results: EPS: ₩1,708 (down from ₩4,013 in FY 2022). Revenue: ₩145.8b (down 20% from FY 2022). Net income: ₩8.10b (down 57% from FY 2022). Profit margin: 5.6% (down from 10% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 14% per year and the company’s share price has also fallen by 14% per year.
分析記事 • Mar 08Tapex Co., Ltd.'s (KRX:055490) Business Is Trailing The Market But Its Shares Aren'tWith a price-to-earnings (or "P/E") ratio of 16.5x Tapex Co., Ltd. ( KRX:055490 ) may be sending bearish signals at the...
Upcoming Dividend • Dec 20Upcoming dividend of ₩900 per share at 3.1% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 11 April 2024. Payout ratio is a comfortable 58% and this is well supported by cash flows. Trailing yield: 3.1%. Lower than top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.8%).
Reported Earnings • Nov 15Third quarter 2023 earnings released: EPS: ₩318 (vs ₩1,185 in 3Q 2022)Third quarter 2023 results: EPS: ₩318 (down from ₩1,185 in 3Q 2022). Revenue: ₩35.7b (down 21% from 3Q 2022). Net income: ₩1.51b (down 73% from 3Q 2022). Profit margin: 4.2% (down from 12% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 3% per year.
Valuation Update With 7 Day Price Move • Nov 03Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₩33,700, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 11% over the past three years.
New Risk • Oct 26New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩131.5b (US$96.8m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (7.1% net profit margin). Market cap is less than US$100m (₩131.5b market cap, or US$96.8m).
Valuation Update With 7 Day Price Move • Aug 09Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩40,500, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 65% over the past three years.
Major Estimate Revision • Apr 29Consensus revenue estimates decrease by 16%The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from ₩229.9m to ₩192.2m. EPS estimate unchanged from ₩4,582 per share at last update. Chemicals industry in South Korea expected to see average net income growth of 31% next year. Consensus price target of ₩100,000 unchanged from last update. Share price fell 3.5% to ₩55,000 over the past week.
Buying Opportunity • Apr 04Now 21% undervaluedOver the last 90 days, the stock is up 16%. The fair value is estimated to be ₩75,380, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 20% over the last 3 years. Earnings per share has grown by 29%. Revenue is forecast to grow by 61% in 2 years. Earnings is forecast to grow by 102% in the next 2 years.
Buying Opportunity • Mar 10Now 23% undervalued after recent price dropOver the last 90 days, the stock is down 1.2%. The fair value is estimated to be ₩75,253, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 20% over the last 3 years. Earnings per share has grown by 29%. Revenue is forecast to grow by 61% in 2 years. Earnings is forecast to grow by 102% in the next 2 years.
Reported Earnings • Mar 09Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: ₩4,013 (up from ₩4,009 in FY 2021). Revenue: ₩182.3b (up 18% from FY 2021). Net income: ₩18.9b (flat on FY 2021). Profit margin: 10% (down from 12% in FY 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 6.0%. Earnings per share (EPS) also missed analyst estimates by 19%. Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Mar 06Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩63,200, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 261% over the past three years.
Buying Opportunity • Jan 16Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 23%. The fair value is estimated to be ₩66,167, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 37%. Revenue is forecast to grow by 48% in 2 years. Earnings is forecast to grow by 60% in the next 2 years.
Upcoming Dividend • Dec 21Upcoming dividend of ₩700 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 12 April 2023. Payout ratio is a comfortable 15% and this is well supported by cash flows. Trailing yield: 1.4%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (2.4%).
Buying Opportunity • Dec 12Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 22%. The fair value is estimated to be ₩72,854, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 37%. Revenue is forecast to grow by 48% in 2 years. Earnings is forecast to grow by 60% in the next 2 years.
Buying Opportunity • Nov 17Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 23%. The fair value is estimated to be ₩79,792, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 37%. Revenue is forecast to grow by 48% in 2 years. Earnings is forecast to grow by 59% in the next 2 years.
Price Target Changed • Nov 16Price target decreased to ₩100,000Down from ₩110,000, the current price target is provided by 1 analyst. New target price is 55% above last closing price of ₩64,600. Stock is down 20% over the past year. The company is forecast to post earnings per share of ₩4,945 for next year compared to ₩4,009 last year.
Reported Earnings • Nov 13Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: ₩45.4b (up 11% from 3Q 2021). Net income: ₩5.59b (up 2.0% from 3Q 2021). Profit margin: 12% (down from 13% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in South Korea.
Buying Opportunity • Nov 07Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 24%. The fair value is estimated to be ₩75,747, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 41%. Revenue is forecast to grow by 43% in 2 years. Earnings is forecast to grow by 51% in the next 2 years.
Reported Earnings • Mar 12Full year 2021 earnings: EPS misses analyst expectationsFull year 2021 results: EPS: ₩4,009 (up from ₩2,931 in FY 2020). Revenue: ₩154.9b (up 30% from FY 2020). Net income: ₩18.9b (up 37% from FY 2020). Profit margin: 12% (in line with FY 2020). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 37%, compared to a 22% growth forecast for the industry in South Korea. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has increased by 57% per year, which means it is tracking significantly ahead of earnings growth.
Upcoming Dividend • Dec 22Upcoming dividend of ₩500 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 15 April 2022. Payout ratio is a comfortable 14% but the company is not cash flow positive. Trailing yield: 0.7%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (1.4%).
Reported Earnings • Nov 13Third quarter 2021 earnings released: EPS ₩1,162 (vs ₩938 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: ₩40.9b (up 28% from 3Q 2020). Net income: ₩5.48b (up 24% from 3Q 2020). Profit margin: 13% (in line with 3Q 2020). Over the last 3 years on average, earnings per share has increased by 48% per year whereas the company’s share price has increased by 49% per year.
Reported Earnings • Aug 12Second quarter 2021 earnings released: EPS ₩1,041 (vs ₩1,038 in 2Q 2020)The company reported a mediocre second quarter result with weaker profit margins, although earnings were flat and revenues improved. Second quarter 2021 results: Revenue: ₩36.3b (up 30% from 2Q 2020). Net income: ₩4.91b (flat on 2Q 2020). Profit margin: 14% (down from 18% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has only increased by 38% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Aug 11Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₩69,400, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 155% over the past three years.
Reported Earnings • May 12First quarter 2021 earnings released: EPS ₩945 (vs ₩437 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ₩33.3b (up 23% from 1Q 2020). Net income: ₩4.46b (up 116% from 1Q 2020). Profit margin: 13% (up from 7.6% in 1Q 2020). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.
分析記事 • May 04Is Tapex Co., Ltd. (KRX:055490) Potentially Undervalued?Tapex Co., Ltd. ( KRX:055490 ), is not the largest company out there, but it led the KOSE gainers with a relatively...
Valuation Update With 7 Day Price Move • Mar 26Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₩51,800, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 91% over the past three years.
分析記事 • Mar 23We Think Tapex (KRX:055490) Can Manage Its Debt With EaseHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Reported Earnings • Mar 10Full year 2020 earnings released: EPS ₩2,931 (vs ₩1,617 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₩118.8b (up 5.5% from FY 2019). Net income: ₩13.8b (up 81% from FY 2019). Profit margin: 12% (up from 6.8% in FY 2019). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.
分析記事 • Mar 08What You Need To Know About Tapex Co., Ltd.'s (KRX:055490) Investor CompositionEvery investor in Tapex Co., Ltd. ( KRX:055490 ) should be aware of the most powerful shareholder groups. Large...
分析記事 • Feb 18Is Tapex (KRX:055490) Likely To Turn Things Around?If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...
お知らせ • Feb 04Tapex Co., Ltd., Annual General Meeting, Mar 22, 2021Tapex Co., Ltd., Annual General Meeting, Mar 22, 2021, at 09:00 Korea Standard Time.
分析記事 • Jan 31Is Tapex Co., Ltd.'s (KRX:055490) Latest Stock Performance A Reflection Of Its Financial Health?Most readers would already be aware that Tapex's (KRX:055490) stock increased significantly by 29% over the past three...
Valuation Update With 7 Day Price Move • Jan 20Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₩42,650, the stock is trading at a trailing P/E ratio of 13.9x, up from the previous P/E ratio of 12x. This compares to an average P/E of 18x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 51%.
分析記事 • Jan 12Should You Rely On Tapex's (KRX:055490) Earnings Growth?Many investors consider it preferable to invest in profitable companies over unprofitable ones, because profitability...
Is New 90 Day High Low • Jan 04New 90-day high: ₩38,550The company is up 25% from its price of ₩30,950 on 06 October 2020. The South Korean market is up 21% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 22% over the same period.
分析記事 • Dec 25Investors Who Bought Tapex (KRX:055490) Shares A Year Ago Are Now Up 65%Passive investing in index funds can generate returns that roughly match the overall market. But investors can boost...
Is New 90 Day High Low • Dec 16New 90-day high: ₩37,700The company is up 8.0% from its price of ₩34,800 on 17 September 2020. The South Korean market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period.
分析記事 • Dec 07Tapex (KRX:055490) Has A Rock Solid Balance SheetSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Is New 90 Day High Low • Nov 30New 90-day high: ₩36,900The company is up 48% from its price of ₩25,000 on 01 September 2020. The South Korean market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period.
Reported Earnings • Nov 14Third quarter 2020 earnings released: EPS ₩938The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: ₩31.8b (up 5.3% from 3Q 2019). Net income: ₩4.43b (up 159% from 3Q 2019). Profit margin: 14% (up from 5.6% in 3Q 2019). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.